§ 829. Prescriptions
1,696 words·~8 min read·
/usc/title-21/section-829A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Schedule II substances Except when dispensed directly by a practitioner, other than a pharmacist, to an ultimate user, no controlled substance in schedule II, which is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], may be dispensed without the written prescription of a practitioner, except that in emergency situations, as prescribed by the Secretary by regulation after consultation with the Attorney General, such drug may be dispensed upon oral prescription in accordance with section 503(b) of that Act [21 U.S.C. 353(b)]. Prescriptions shall be retained in conformity with the requirements of section 827 of this title. No prescription for a controlled substance in schedule II may be refilled.
(b)Schedule III and IV substances Except when dispensed directly by a practitioner, other than a pharmacist, to an ultimate user, no controlled substance in schedule III or IV, which is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.], may be dispensed without a written or oral prescription in conformity with section 503(b) of that Act [21 U.S.C. 353(b)]. Such prescriptions may not be filled or refilled more than six months after the date thereof or be refilled more than five times after the date of the prescription unless renewed by the practitioner.
(c)Schedule V substances No controlled substance in schedule V which is a drug may be distributed or dispensed other than for a medical purpose.
(d)Non-prescription drugs with abuse potential Whenever it appears to the Attorney General that a drug not considered to be a prescription drug under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] should be so considered because of its abuse potential, he shall so advise the Secretary and furnish to him all available data relevant thereto.
(e)Controlled substances dispensed by means of the Internet
(1)No controlled substance that is a prescription drug as determined under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] may be delivered, distributed, or dispensed by means of the Internet without a valid prescription.
(2)As used in this subsection:
(A)The term “valid prescription” means a prescription that is issued for a legitimate medical purpose in the usual course of professional practice by—
(i)a practitioner who has conducted at least 1 in-person medical evaluation of the patient; or
(ii)a covering practitioner.
(i)The term “in-person medical evaluation” means a medical evaluation that is conducted with the patient in the physical presence of the practitioner, without regard to whether portions of the evaluation are conducted by other health professionals.
(ii)Nothing in clause
(i)shall be construed to imply that 1 in-person medical evaluation demonstrates that a prescription has been issued for a legitimate medical purpose within the usual course of professional practice.
(C)The term “covering practitioner” means, with respect to a patient, a practitioner who conducts a medical evaluation (other than an in-person medical evaluation) at the request of a practitioner who—
(i)has conducted at least 1 in-person medical evaluation of the patient or an evaluation of the patient through the practice of telemedicine, within the previous 24 months; and
(ii)is temporarily unavailable to conduct the evaluation of the patient.
(3)Nothing in this subsection shall apply to—
(A)the delivery, distribution, or dispensing of a controlled substance by a practitioner engaged in the practice of telemedicine; or
(B)the dispensing or selling of a controlled substance pursuant to practices as determined by the Attorney General by regulation, which shall be consistent with effective controls against diversion.
(f)Partial fills of schedule II controlled substances
(1)Partial fills A prescription for a controlled substance in schedule II may be partially filled if—
(A)it is not prohibited by State law;
(B)the prescription is written and filled in accordance with this subchapter, regulations prescribed by the Attorney General, and State law;
(C)the partial fill is requested by the patient or the practitioner that wrote the prescription; and
(D)the total quantity dispensed in all partial fillings does not exceed the total quantity prescribed.
(2)Remaining portions
(A)In general Except as provided in subparagraph (B), remaining portions of a partially filled prescription for a controlled substance in schedule II—
(i)may be filled; and
(ii)shall be filled not later than 30 days after the date on which the prescription is written.
(B)Emergency situations In emergency situations, as described in subsection (a), the remaining portions of a partially filled prescription for a controlled substance in schedule II—
(i)may be filled; and
(ii)shall be filled not later than 72 hours after the prescription is issued.
(3)Currently lawful partial fills Notwithstanding paragraph
(1)or (2), in any circumstance in which, as of the day before July 22, 2016, a prescription for a controlled substance in schedule II may be lawfully partially filled, the Attorney General may allow such a prescription to be partially filled.
(Pub. L. 91–513, title II, § 309, Oct. 27, 1970, 84 Stat. 1260; Pub. L. 110–425, § 2, Oct. 15, 2008, 122 Stat. 4820; Pub. L. 114–198, title VII, § 702(a), July 22, 2016, 130 Stat. 740.)
Connections448 cite this · traces to 11
Cited by 448 sections · top 60
U.S. Code
public-private-law
- Public Law 117-328Consolidated Appropriations Act, 2023
- Public Law 115-271Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act
- Public Law 114-198Comprehensive Addiction and Recovery Act of 2016
- Public Law 116-215Further Continuing Appropriations Act, 2021, and Other Extensions Act
CFR
register
- Presidential DocumentsIntroduction to the Regulatory Plan and the Unified Agenda of Federal Regulatory and Deregulatory Actions
- Proposed RulesNotice of proposed rulemaking
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesFinal rule
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- Rules and RegulationsFinal rule
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- Rules and RegulationsInterim final rule; request for comments
- UnknownRule of Agency Procedure
- Rules and RegulationsInterim final rule, with request for comments
- NoticesDEPARTMENT OF JUSTICE
- NoticesNotice
- Proposed RulesNotice of proposed rulemaking
- NoticesDEPARTMENT OF JUSTICE
- Proposed RulesNotice of proposed rulemaking
- Rules and RegulationsFinal rule
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesNotice of information collection
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- Rules and RegulationsFinal rule
- NoticesDEPARTMENT OF JUSTICE
- Rules and RegulationsDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesFinal rule
- NoticesInterim Final Rule with Request for Comment
- NoticesDEPARTMENT OF JUSTICE
- Rules and RegulationsFinal rule
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
- NoticesDEPARTMENT OF JUSTICE
statutes-at-large
- Public Law 114–198To authorize the Attorney General and Secretary of Health and Human Services to award grants to address the prescription opioid abuse and heroin use crisis, and for other purposes
- Public Law 95–633To amend the Comprehensive Drug Abuse Prevention and Control Act of 1970 and other laws to meet obligations under the Convention on Psychotropic Substances relating to regulatory controls on the manufacture, distribution, importation, and exportation of psychotropic substances, and for other purpose
- Public Law 115–271To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes
Traces to 11 documents
U.S. Code
public-private-law
- Comprehensive Addiction and Recovery Act of 2016Public Law 114-198
- Further Continuing Appropriations Act, 2021, and Other Extensions ActPublic Law 116-215
- Substance Use–Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities ActPublic Law 115-271
- Consolidated Appropriations Act, 2023Public Law 117-328
16 references not yet in our index
- Pub. L. 91–513, title II, § 309
- 84 Stat. 1260
- Pub. L. 110–425, § 2
- 122 Stat. 4820
- 130 Stat. 740
- act June 25, 1938, ch. 675
- 52 Stat. 1040
- Pub. L. 110–425
- section 3(j) of Pub. L. 110–425
- section 704 of Pub. L. 91–513
- 130 Stat. 741
- 134 Stat. 1046
- 132 Stat. 3947
- 136 Stat. 5685
- Pub. L. 101–647, title XIX, § 1902(c)
- 104 Stat. 4852
Citation graph
cites case law
§ 829
Prescriptions
Fed. Reg.×338
Bills×63
Stat.×14
C.F.R.×9
Pub. L.×9
U.S.C.×8
Stat. Comp.×7
Pub. L.Pub. L. 91–513, title II, § 309
Stat.84 Stat. 1260
Pub. L.Pub. L. 110–425, § 2
Cites 27 · showing 12Cited by 448 across 7 sources